Stanley Hirsch is Director at Foamix Pharmaceuticals Ltd. (FOMX). They have made 1 open-market trade across 1 company since 2018, most recently 2020-04-03.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FOMX | SELL | 2018-05-13 | 2018-05-31 | $5.09 | $31K | -1.1% | -1.9% | +9.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.